Integrated genomic and epigenomic analysis of blood circulation tumor DNA from gastric cancer and gastric GIST patients

Not Applicable

• Conditions: Gastric cancer, GIST

• Registration Number: JPRN-UMIN000040148
• Lead Sponsor: ational Cancer Center Hospital East

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-04-13
• Last Update Posted: 17 October 2023
• Study Completion: 2027-09-30

Recruitment & Eligibility

• Status: Complete: follow-up continuing
• Sex: All
• Target Recruitment: 600

Inclusion Criteria

Not provided

Exclusion Criteria

Gastric cancer cohort 1. a history of malignancy (including gastric cancer) with a disease-free period of up to 10 years. 2.Duplicate cancers are suspected on chest and pelvic CT scan within 60 days before enrollment. 3. Are pregnant. 4. the attending physician determines that you are unsuitable for enrollment in the study. Gastric GIST cohort A 1.History of malignancy (including gastric GIST) with a disease-free period of up to 10 years. 2.Duplicate cancers are suspected by chest and pelvic CT scan within 60 days before enrollment. 3.Are pregnant. 4.Your physician determines that you are unsuitable for enrollment in the study. Gastric GIST cohort B 1.A history of malignancy (including gastric GIST) with a disease-free period of up to 10 years prior to resection of gastric GIST with eligibility criterion 2. 2.Duplicate cancers are suspected by chest and pelvic CT scan within 60 days before enrollment. 3.Are pregnant. 4.Your physician determines that you are unsuitable for enrollment in the study.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Positive rate of LUNAR assay in Stage-I-III gastric cancer and gastric GIST